Proyectos de Investigación
Project
IMMUTOL - Advanced antigen-specific dendritic cell-based therapy to re-establish tolerance in immunemediated diseases
Funder: COMISIÓN EUROPEA
Call: HORIZON-HLTH-2022-DISEASE-06-two-stage (COMISIÓN EUROPEA)
edit_calendar
Duration: from 01 April 2023 to 31 December 2026
(45 months)
Current
€900,000.00
Of European scope.
